RESUMEN
BACKGROUND AND OBJECTIVE: Atorvastatin (ATV) has bone anabolic properties, and alendronate (ALD) is an important antiresorptive drug. This study aimed to evaluate the effects of the combination of ALD and ATV on ligature-induced alveolar bone loss in rats. MATERIAL AND METHODS: Periodontitis was induced by ligature in 78 Wistar rats. Groups of six rats prophylactically received 0.9% saline (SAL), ALD (0.01 or 0.25 mg/kg subcutaneously) or ATV (0.3 or 27 mg/kg by gavage). Then, groups of six rats received the combination of ALD+ATV (0.25 mg/kg + 27 mg/kg, 0.01 mg/kg + 0.3 mg/kg, 0.25 mg/kg + 0.3 mg/kg or 0.01 mg/kg + 27 mg/kg) prophylactically. An extra group of six rats received therapeutic SAL or a lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively) therapeutically. Three extra groups of six rats each received SAL or a lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively) prophylactically or therapeutically for histometric and immunohistochemical analyses. The rats were killed on day 11 after ligature placement, and the maxillae were removed and processed for macroscopic, histomorphometric and TRAP immunohistochemical analyses. Gingival samples were collected to evaluate myeloperoxidase (MPO) activity. Blood samples were collected to measure serum bone-specific alkaline phosphatase (BALP) and transaminase levels and for hematological studies. Rats were weighed daily. RESULTS: All combined therapies prevented alveolar bone loss when compared with SAL or low doses of monotherapy (ALD or ATV) (p < 0.05). The lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively), administered either prophylactically (39.0%) or therapeutically (53.5%), prevented alveolar bone loss. Decreases in bone and cementum resorption, in leukocyte infiltration and in immunostaining for TRAP and MPO activity corroborated the morphometric findings. The lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively) prevented BALP reduction (p < 0.05) and did not alter the level of serum transaminases. Moreover, the lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively) also reduced neutrophilia and lymphomonocytosis and did not cause weight loss when compared with administration of SAL. CONCLUSION: The lower-dose combination of ALD+ATV (0.01 mg/kg + 0.3 mg/kg, respectively) demonstrated a protective effect on alveolar bone loss.
Asunto(s)
Alendronato/administración & dosificación , Pérdida de Hueso Alveolar/prevención & control , Conservadores de la Densidad Ósea/administración & dosificación , Ácidos Heptanoicos/administración & dosificación , Inhibidores de Hidroximetilglutaril-CoA Reductasas/administración & dosificación , Pirroles/administración & dosificación , Fosfatasa Ácida/análisis , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Animales , Aspartato Aminotransferasas/sangre , Atorvastatina , Peso Corporal , Cemento Dental/efectos de los fármacos , Encía/enzimología , Infusiones Parenterales , Inyecciones Subcutáneas , Isoenzimas/análisis , Trastornos Leucocíticos/prevención & control , Leucocitos/efectos de los fármacos , Leucocitosis/prevención & control , Masculino , Monocitos/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Peroxidasa/análisis , Ratas Wistar , Resorción Radicular/prevención & control , Fosfatasa Ácida TartratorresistenteRESUMEN
Clinical oncology has shown outstanding progress improving patient survival due to the incorporation of new drugs. However, treatment success may be reduced by the emergency of dose-limiting side effects, such as intestinal mucositis and diarrhea. Mucositis and diarrhea management is symptomatic, and there is no preventive therapy. Bacterial and fungal-based compounds have been suggested as an alternative for preventing the development of diarrhea in cancer patients. Using probiotics is safe and effective in immunocompetent individuals, but concerns remain during immunosuppressive conditions. Paraprobiotics, formulations composed of non-viable microorganisms, have been proposed to overcome such limitation. The present literature review discusses current evidence regarding the possible use of paraprobiotics as an alternative to probiotics to prevent gastrointestinal toxicity of cancer chemotherapy.
Asunto(s)
Antineoplásicos , Mucositis , Neoplasias , Probióticos , Humanos , Antineoplásicos/efectos adversos , Diarrea/inducido químicamente , Diarrea/prevención & control , Mucositis/inducido químicamente , Mucositis/tratamiento farmacológico , Neoplasias/tratamiento farmacológico , Probióticos/uso terapéutico , Probióticos/farmacologíaRESUMEN
It was previously demonstrated that the methanol fraction of Sideroxylon obtusifolium (MFSOL) promoted anti-inflammatory and healing activity in excisional wounds. Thus, the present work investigated the healing effects of MFSOL on human keratinocyte cells (HaCaT) and experimental burn model injuries. HaCaT cells were used to study MFSOL's effect on cell migration and proliferation rates. Female Swiss mice were subjected to a second-degree superficial burn protocol and divided into four treatment groups: Vehicle, 1.0% silver sulfadiazine, and 0.5 or 1.0% MFSOL Cream (CrMFSOL). Samples were collected to quantify the inflammatory mediators, and histological analyses were performed after 3, 7, and 14 days. The results showed that MFSOL (50 µg/mL) stimulated HaCaT cells by increasing proliferation and migration rates. Moreover, 0.5% CrMFSOL attenuated myeloperoxidase (MPO) activity and also stimulated the release of interleukin (IL)-1ß and IL-10 after 3 days of treatment. CrMFSOL (0.5%) also enhanced wound contraction, promoted improvement of tissue remodeling, and increased collagen production after 7 days and VEGF release after 14 days. Therefore, MFSOL stimulated human keratinocyte (HaCaT) cells and improved wound healing via modulation of inflammatory mediators of burn injuries.
Asunto(s)
Quemaduras , Sapotaceae , Quemaduras/tratamiento farmacológico , Femenino , Humanos , Queratinocitos , Metanol , Hojas de la Planta , Prolina , Cicatrización de HeridasRESUMEN
OBJECTIVES: To study and characterize the in vivo effect of the lectin from Luetzelburgia auriculata seed on acute inflammation models. METHODS: The lectin was purified from the crude saline extract by affinity chromatography on a guar-gum matrix. Native, heat-treated, and digested lectin was evaluated for anti-inflammatory activity by using peritonitis and paw edema models. The anti-inflammatory activity was characterized by intravital microscopy, nitric oxide production, and myeloperoxidase activity. RESULTS: The lectin exhibited anti-inflammatory activity (2 mg/kg) on both models, reducing local myeloperoxidase activity. Galactose or heat treatment (100 degrees C, 10 min) reduced anti-inflammatory action. Anti-inflammation involves the inhibition of adhesion and rolling of leukocytes along with augmentation of nitric oxide in serum. The lectin inhibited the edematogenic effect of histamine and prostaglandins (PGE2) but did not alter the chemoattractant effect of IL-8. CONCLUSIONS: The results indicate that this lectin is a potent anti-inflammatory molecule. Its effects engage diverse modulatory events.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Adhesión Celular/efectos de los fármacos , Dinoprostona/antagonistas & inhibidores , Fabaceae/química , Antagonistas de los Receptores Histamínicos , Inflamación/tratamiento farmacológico , Rodamiento de Leucocito/efectos de los fármacos , Leucocitos/efectos de los fármacos , Lectinas de Plantas/farmacología , Animales , Antiinflamatorios no Esteroideos/química , Carragenina , Quimiotaxis de Leucocito/efectos de los fármacos , Dinoprostona/farmacología , Edema/inducido químicamente , Edema/prevención & control , Electroforesis en Gel de Poliacrilamida , Galactosa/metabolismo , Indicadores y Reactivos , Inflamación/enzimología , Inflamación/patología , Neutrófilos/efectos de los fármacos , Óxido Nítrico/metabolismo , Peritonitis/inducido químicamente , Peritonitis/tratamiento farmacológico , Peroxidasa/metabolismo , Lectinas de Plantas/química , Ratas , Ratas Wistar , Semillas/químicaRESUMEN
Oral mucositis (OM) is a common and dose-limiting side effect of cancer treatment, including 5-fluorouracil (5-FU) and radiotherapy. The efficacy of the therapeutic measures to prevent OM is limited and disease prevention is not fully observable. Amifostine is a cytoprotective agent with a described anti-inflammatory potential. It is clinically used to reduce radiotherapy and chemotherapy-associated xerostomia. This study investigated the protective effect of amifostine on an experimental model of OM. Hamsters were divided into six groups: saline control group (5 mL/kg), mechanical trauma (scratches) of the right cheek pouch; 5-FU (60 and 40 mg/kg, ip, respectively, administered on days 1 and 2); amifostine (12.5, 25, or 50 mg/kg) + 5-FU + scratches. Salivation rate was assessed and the animals were euthanized on day 10 for the analysis of macroscopic and microscopic injury by scores. Tissue samples were harvested for the measurement of neutrophil infiltration and detection of inflammatory markers by ELISA and immunohistochemistry. 5-FU induced pronounced hyposalivation, which was prevented by amifostine (P<0.05). In addition, 5-FU injection caused pronounced tissue injury accompanied by increased neutrophil accumulation, tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1ß) tissue levels, and positive immunostaining for TNF-α, IL-1ß, and inducible nitric oxide synthase (iNOS). Interestingly, amifostine prevented the inflammatory reaction and consequently improved macroscopic and microscopic damage (P<0.05 vs 5-FU group). Amifostine reduced inflammation and protected against 5-FU-associated oral mucositis and hyposalivation.
Asunto(s)
Amifostina/uso terapéutico , Fluorouracilo/efectos adversos , Inflamación/prevención & control , Sustancias Protectoras/uso terapéutico , Estomatitis/prevención & control , Xerostomía/prevención & control , Animales , Cricetinae , Modelos Animales de Enfermedad , Inflamación/inducido químicamente , Inflamación/patología , Masculino , Estomatitis/inducido químicamente , Estomatitis/patología , Xerostomía/inducido químicamente , Xerostomía/patologíaRESUMEN
Immunological and allergenic responses against the latex of Calotropis procera were investigated in mice by oral and subcutaneous routes. The latex was fractionated according to water solubility and molecular size of its components. The fractions were named as non-dialyzable latex (NDL) corresponding to the major latex proteins, dialyzable latex (DL) corresponding to low molecular size substances and rubber latex (RL) which was highly insoluble in water. Anti-sera against these fractions were assayed for total IgG and IgA titration by ELISA and IgE and IgG(1) were quantified by passive cutaneous anaphylaxis (PCA) in rats and mice, respectively. None of the fractions induced antibodies level increases when mice received latex fractions by oral route and thus, did not develop allergy. Nonetheless, anti-sera of mice sensitized with NDL and RL by subcutaneous route displayed considerable immunological response while DL did not. IgG level augmented consistently against NDL and RL while IgA response was detected only to NDL. NDL and RL induced very strong PCA reactions suggesting that both fractions would contain latex substances involved in allergy. Furthermore, protein analysis of NDL and RL suggests that RL still retain residual proteins abundantly found in NDL that could explain its similar allergenic effect. No IgG(1) reaction was detected in any of the anti-sera tested. According to the results, the proteins of latex of Calotropis procera can provoke allergy by subcutaneous route. The NDL has previously shown to display anti-inflammatory and analgesic activities by intraperitoneal injection. It should be relevant to determine whether NDL could induce such activities when assayed by oral route since it was ineffective to induce allergy by this way.
Asunto(s)
Formación de Anticuerpos , Antígenos de Plantas/administración & dosificación , Antígenos de Plantas/farmacología , Calotropis , Hipersensibilidad al Látex/inmunología , Látex/administración & dosificación , Látex/inmunología , Administración Oral , Animales , Antígenos de Plantas/química , Brasil , Fraccionamiento Químico , Relación Dosis-Respuesta Inmunológica , Ensayo de Inmunoadsorción Enzimática , Inmunización , Inmunoglobulina A/sangre , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Inyecciones Subcutáneas , Látex/química , Masculino , Ratones , Peso Molecular , Anafilaxis Cutánea Pasiva , Extractos Vegetales/administración & dosificación , Extractos Vegetales/inmunología , Ratas , Solubilidad , Solventes/química , Factores de Tiempo , Agua/químicaRESUMEN
Clinical oncology has shown outstanding progress improving patient survival due to the incorporation of new drugs. However, treatment success may be reduced by the emergency of dose-limiting side effects, such as intestinal mucositis and diarrhea. Mucositis and diarrhea management is symptomatic, and there is no preventive therapy. Bacterial and fungal-based compounds have been suggested as an alternative for preventing the development of diarrhea in cancer patients. Using probiotics is safe and effective in immunocompetent individuals, but concerns remain during immunosuppressive conditions. Paraprobiotics, formulations composed of non-viable microorganisms, have been proposed to overcome such limitation. The present literature review discusses current evidence regarding the possible use of paraprobiotics as an alternative to probiotics to prevent gastrointestinal toxicity of cancer chemotherapy.
RESUMEN
It was previously demonstrated that the methanol fraction of Sideroxylon obtusifolium (MFSOL) promoted anti-inflammatory and healing activity in excisional wounds. Thus, the present work investigated the healing effects of MFSOL on human keratinocyte cells (HaCaT) and experimental burn model injuries. HaCaT cells were used to study MFSOL's effect on cell migration and proliferation rates. Female Swiss mice were subjected to a second-degree superficial burn protocol and divided into four treatment groups: Vehicle, 1.0% silver sulfadiazine, and 0.5 or 1.0% MFSOL Cream (CrMFSOL). Samples were collected to quantify the inflammatory mediators, and histological analyses were performed after 3, 7, and 14 days. The results showed that MFSOL (50 μg/mL) stimulated HaCaT cells by increasing proliferation and migration rates. Moreover, 0.5% CrMFSOL attenuated myeloperoxidase (MPO) activity and also stimulated the release of interleukin (IL)-1β and IL-10 after 3 days of treatment. CrMFSOL (0.5%) also enhanced wound contraction, promoted improvement of tissue remodeling, and increased collagen production after 7 days and VEGF release after 14 days. Therefore, MFSOL stimulated human keratinocyte (HaCaT) cells and improved wound healing via modulation of inflammatory mediators of burn injuries.
Asunto(s)
Humanos , Femenino , Quemaduras/tratamiento farmacológico , Sapotaceae , Prolina , Queratinocitos , Hojas de la Planta , MetanolRESUMEN
We have investigated the anti-inflammatory and antimicrobial effect of the lectin from Lonchocarpus sericeus seeds (LSL) in a model of infectious peritonitis in adult Wistar rats. Animals were treated with saline or LSL (10 mg kg(-1), i.v) immediately and 6 h after the induction of peritonitis via cecal ligation and single puncture. Twelve hours after surgery, animals were killed and the infectious process was monitored by total and differential count of cells from blood and peritoneal washing liquid, adenosine deaminase activity, antibiogram and the number of viable bacteria of the peritoneal cavity. LSL treatment decreased the inflammatory response evoked by the induction of peritonitis, as seen by the inhibition of neutrophil migration into peritoneal cavities, leucocytosis and reduction of adenosine deaminase activity in the peritoneal fluid. All these effects were reversed by the lectin association to N-acetyl-glucosamine. LSL in-vitro did not show any antimicrobial action, but promoted a marked decrease of the viable bacterial population in peritoneal cavities. In conclusion, LSL inhibited the inflammatory response and the bacterial colonization of infectious peritonitis in rats.
Asunto(s)
Derris/química , Peritonitis/tratamiento farmacológico , Extractos Vegetales/farmacología , Animales , Bacterias/efectos de los fármacos , Bacterias/genética , Movimiento Celular , Inflamación , Lectinas , Masculino , Neutrófilos/efectos de los fármacos , Neutrófilos/fisiología , Peritonitis/veterinaria , Ratas , Ratas Wistar , Semillas/químicaRESUMEN
PAL is a glucose/mannose-specific lectin isolated from Pisum arvense seeds. Previously, we demonstrated the capacity of other leguminous lectins to induce oedema formation and neutrophil stimulation. To investigate the potential pro-inflammatory activity of PAL, we have studied its ability to induce neutrophil migration into peritoneal cavities of rats and neutrophil chemotaxis in-vitro. The role of resident cells and sugar residues on PAL activity was analysed. PAL or saline (control) were administered intraperitoneally to rats, and total and differential leucocyte (macrophages, neutrophils and mast cells) counts were performed. The role of resident cells on the PAL effect was evaluated using three strategies: reducing the total resident cell population by lavage of rat cavities with saline; increasing macrophage population by treating animals with thioglycolate; and depleting mast cell population by subchronic treatment of rats with compound 48/80. PAL induced in-vitro and in-vivo neutrophil migration. In-vivo, PAL (50, 100, 200 and 300 microg) significantly (P < 0.05) and dose-dependently increased neutrophil migration by 600, 740, 900 and 940%, respectively, showing maximal effect 4 h after injection. PAL induced mononuclear cell migration. The neutrophil stimulatory effect of PAL was potentiated in animals treated with both thioglycolate and compound 48/ 80. The indirect lectin chemotactic effect was shown in rats injected with supernatant from cultured macrophages stimulated by PAL. In conclusion, PAL was shown to exhibit in-vivo and in-vitro proinflammatory activity. The in-vivo effect seemed to occur by a dual mechanism that was independent, but also dependent, on resident cells.
Asunto(s)
Quimiotaxis de Leucocito , Neutrófilos/efectos de los fármacos , Lectinas de Plantas/farmacología , Semillas/química , Animales , Relación Dosis-Respuesta a Droga , Femenino , Técnicas In Vitro , Macrófagos Peritoneales/metabolismo , Masculino , Mastocitos/metabolismo , Neutrófilos/fisiología , Cavidad Peritoneal/citología , Lavado Peritoneal , Ratas , Ratas WistarRESUMEN
Oral mucositis (OM) is a common and dose-limiting side effect of cancer treatment, including 5-fluorouracil (5-FU) and radiotherapy. The efficacy of the therapeutic measures to prevent OM is limited and disease prevention is not fully observable. Amifostine is a cytoprotective agent with a described anti-inflammatory potential. It is clinically used to reduce radiotherapy and chemotherapy-associated xerostomia. This study investigated the protective effect of amifostine on an experimental model of OM. Hamsters were divided into six groups: saline control group (5 mL/kg), mechanical trauma (scratches) of the right cheek pouch; 5-FU (60 and 40 mg/kg, ip, respectively, administered on days 1 and 2); amifostine (12.5, 25, or 50 mg/kg) + 5-FU + scratches. Salivation rate was assessed and the animals were euthanized on day 10 for the analysis of macroscopic and microscopic injury by scores. Tissue samples were harvested for the measurement of neutrophil infiltration and detection of inflammatory markers by ELISA and immunohistochemistry. 5-FU induced pronounced hyposalivation, which was prevented by amifostine (P<0.05). In addition, 5-FU injection caused pronounced tissue injury accompanied by increased neutrophil accumulation, tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β) tissue levels, and positive immunostaining for TNF-α, IL-1β, and inducible nitric oxide synthase (iNOS). Interestingly, amifostine prevented the inflammatory reaction and consequently improved macroscopic and microscopic damage (P<0.05 vs 5-FU group). Amifostine reduced inflammation and protected against 5-FU-associated oral mucositis and hyposalivation.
Asunto(s)
Animales , Masculino , Estomatitis/prevención & control , Xerostomía/prevención & control , Amifostina/uso terapéutico , Sustancias Protectoras/uso terapéutico , Fluorouracilo/efectos adversos , Inflamación/prevención & control , Estomatitis/inducido químicamente , Estomatitis/patología , Xerostomía/inducido químicamente , Xerostomía/patología , Cricetinae , Modelos Animales de Enfermedad , Inflamación/inducido químicamente , Inflamación/patologíaRESUMEN
PURPOSE: Oral mucositis (OM) is a frequent side effect in patients with cancer. We investigate the effect of atorvastatin (ATV), a cholesterol-lowering drug, on OM induced by 5-fluorouracil (5-FU) in hamsters. METHODS: OM was induced by the i.p. administration of 5-FU, with excoriations of the cheek pouch mucosa. The animals were pretreated with i.p. ATV 1, 5 or 10 mg/kg or vehicle (saline and 5% (vol/vol) ethanol) 30 min before 5-FU injection and daily for 5 or 10 days. Samples of cheek pouches and main organs were removed for histopathological analysis, determination of TNF-α, IL-1ß, nitrite, non-protein sulfhydryl group (NP-SH) levels, myeloperoxidase (MPO) assay and immunohistochemistry for induced nitric oxide synthase (iNOS). Blood was collected for a leukogram analysis of biochemical parameters and analysis of bacteremia. RESULTS: ATV at doses of 1 and 5 mg/kg reduced mucosal damage and inflammation, as well as the levels of cytokines, nitrite and myeloperoxidase activity on the 5th and 10th day of OM and immunostaining for iNOS on the 5th day of OM.ATV at 1 mg/kg increased cheek pouch NP-SH when compared to 5-FU groups on the 10th day of OM. The association between ATV 5 mg/kg and 5-FU decreased the survival rate, amplified the leukopenia of animals, increased transaminase serum levels and caused liver lesions. We also detected the presence of Gram-negative bacillus in the blood of 100% of the animals treated with ATV 5 mg/kg + 5-FU. CONCLUSIONS: Atorvastatin prevented mucosal damage and inflammation associated with 5-FU-induced OM, but the association of a higher dose of ATV with 5-FU induced hepatotoxicity and amplified leukopenia.
Asunto(s)
Antiinflamatorios no Esteroideos/toxicidad , Antimetabolitos Antineoplásicos/toxicidad , Fluorouracilo/toxicidad , Ácidos Heptanoicos/uso terapéutico , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Pirroles/uso terapéutico , Estomatitis/tratamiento farmacológico , Animales , Atorvastatina , Bacteriemia/inducido químicamente , Bacteriemia/microbiología , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Cricetinae , Citocinas/metabolismo , Relación Dosis-Respuesta a Droga , Ácidos Heptanoicos/efectos adversos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos , Leucopenia/inducido químicamente , Masculino , Mesocricetus , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/patología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nitritos/metabolismo , Peroxidasa/metabolismo , Pirroles/efectos adversos , Estomatitis/inducido químicamente , Estomatitis/patología , Compuestos de Sulfhidrilo/metabolismoRESUMEN
OBJECTIVES AND DESIGN: Previous studies have described pro- and anti-inflammatory activities displayed by the latex from Calotropis procera. This report aims to clarify these observations and shows that such activities can be segregated from the whole latex. METHODS: The latex was divided into water-soluble fractions devoid of poly-isoprene by centrifugation and dialysis and both the activities were assayed by the peritonitis model in rats. The drugs dexamethasone, thalidomide, meclizine, indomethacin and celecoxib were used to modulate the inflammatory stimuli. RESULTS: Inflammation in rats was observed 2 h after intraperitoneal administration of the stimulus (DL fraction) in a dose dependent manner. This activity was inhibited by previous intravenous injection of dexamethasone, thalidomide and meclizine. Indomethacin and celecoxib did not reverse inflammation. These results suggest the involvement of histamine release and TNF-alpha mediated inflammation while prostaglandins seem not to be required. The anti-inflammatory fraction (NDL) inhibited inflammation triggered by proinflammatory fraction (DL) suggesting that NDL ought to follow a similar pathway of action to that of the anti-inflammatory drugs that were able to inhibit inflammation triggered by DL. CONCLUSIONS: Pro- and anti-inflammatory activities of the latex are displayed by compounds suitable to be fractionated on the basis of their molecular size.
Asunto(s)
Calotropis , Látex , Animales , Antiinflamatorios/farmacología , Ratas Wistar , Diálisis RenalRESUMEN
Latex from Calotropis procera is widely used in folk medicine as a rich source of biologically active compounds capable of promoting diverse benefits such as control of dermal fungal infections, antimicrobial activities and pain relief among other useful properties. The aim of this work was to characterize the anti-inflammatory effect of a non-dialysable protein fraction recovered from the rubber-free latex using three different experimental models when administrated intravenously. In vivo neutrophil migration induced by carrageenin (500 microg) was severely inhibited by doses of latex proteins reaching maximum inhibition (80%) at 100 mg/kg. Paw edema exacerbated by the effect of carrageenin was almost completely suppressed after 4 hours and was controlled within the first hour following latex protein administration. However, the same latex fraction was completely unable to control the paw edema invoked with dextran stimulation (400 microg), suggesting that the inhibitory effect of the latex is likely to be cell-mediated. Iphosphamide-induced vesical edema in mice was also largely prevented by the latex protein fraction. These results indicate that an effect similar to that of mesna, the classical drug used for this purpose, is operative. Our findings suggest that the sample tested seems to act over a wide spectrum as a novel anti-inflammatory agent. The results also suggest that the active molecules are of a proteinaceous nature despite the presence of numerous secondary metabolites naturally occurring in the C. procera latex.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Calotropis , Fitoterapia , Extractos Vegetales/farmacología , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/uso terapéutico , Carragenina , Relación Dosis-Respuesta a Droga , Edema/inducido químicamente , Edema/prevención & control , Inyecciones Intravenosas , Látex , Masculino , Peritonitis/inducido químicamente , Peritonitis/prevención & control , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Ratas , Ratas Wistar , Enfermedades de la Vejiga Urinaria/prevención & controlRESUMEN
O exame sumário de urina representa sem dúvida um elemento indispensável na detecçäo de diversas doenças do trato urinário, metabólicas ou sistêmicas näo relacionadas com o rim. Quando realizado e interpretado criteriosamente, oferece ao solicitante valiosas informaçöes para o esclarecimento diagnóstico. O presente trabalho tem como objetivo propor um modelo de padronizaçäo de resultados, descritos de acordo com o exame físico (volume, cor, aspecto, depósito e densidade), pesquisas bioquímicas realizadas através de tiras reativas (pH, proteínas, glicose, corpos cetônicos, hemoglobina, urobilinogênio, bilirrubina, esterase leucocitária e nitrito) e os elementos encontrados na sedimentoscopia urinária (células epiteliais de descamaçäo, leucócitos, hemácias, cilindros, bactérias, muco, cristais, sais amorfos, leveduras, espermatozóides e parasitas). Além desses parâmetros, algumas observaçöes podem ser descritas, quando necessárias, com a finalidade de fornecer informaçöes ao clínico que possam auxiliar no diagnóstico de doenças mais específicas. Sabe-se da existência de vários interferentes na urina que podem provocar reaçöes falso-negativas. Por este motivo, a confirmaçäo de alguns componentes urinários (proteínas, glicose, bilirrubina e urobilinogênio) é necessária para garantir a exatidäo do resultado. A padronizaçäo de procedimentos poderá evitar as diferentes formas de transcriçäo do laudo interlaboratorial, o que ocasiona interpretaçäo e tratamento inadequados
Asunto(s)
Humanos , Técnicas de Laboratorio Clínico , Urinálisis/normas , Enfermedades Urológicas/diagnósticoRESUMEN
Estudos têm demonstrado que 81 por cento dos pacientes infectados pelo HIV apresentam um padräo proteico anormal devido ao estado hipermetabólico. Os achados laboratoriais revelam que as anormalidades da imunidade humoral precedem a imunidade mediada pelas células e portanto, o diagnóstico da infecçäo pelo HIV depende do estabelecimento da infecçäo definindo o estado imunológico e o quadro clínico do paciente que ocorre secundário à infecçä e à perda da funçäo imune. No presente trabalho, realizamos um estudo comparativo do perfil eletroforético das proteínas, bem como a determinaçäo da concentraçäo das imunoglobulinas plasmáticas em pacientes portadores de HIV (assintomáticos e sintomáticos) com o objetivo de investigarmos alteraçöes específicas das fraçöes protéicas (albumina e globulina) durante os diferentes estágios da doença. Foram analisadas 30 amostras de sangue coletado de pacientes HIV positivos divididos em dois grupos (assintomáticos e sintomáticos). As proteínas totais foram determinadas pelo método do Biureto, sendo observada uma hipoproteinemia em 60 por cento dos pacientes sintomáticos e valores normais em todos os assintomáticos. A eletroforese das proteínas foi realizada em gel de agarose mostrando hipoalbuminemia em 70 por cento dos pacientes assintomáticos e 90 por cento sintomáticos. A hipergamaglobulinemia predominou em 100 por cento dos sintomáticos e 90 por cento dos assintomáticos. As fraçöes alfa e beta globulinas apresentaram-se normais nos dois grupos. As imunoglobulinas foram avaliadas por turbidimetria e uma elevaçäo significativa foi verificada na concentraçäo de IgG em todos os pacientes sintomáticos. Por outro lado, os valores de IgA e IgM apresentaram-se dentro dos valores de referência. Os resultados estäo de acordo com vários trabalhos citados na literatura, comprovando que a AIDS é uma gamopatia monoclonal, caracterizada por hipoalbuminemia e hipergamaglobulinemia. O trabalho mostra portanto, que, a avaliaçäo de parâmetros laboratoriais mais simples säo úteis no monitoramento da síndrome em estudo, como também fortes indicadores do estágio da doença.